Lumbos, Marypearl .
HRN: 28=96-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2026
05/14/2026
IV
500mg
Q8
Uti Acute Ap
Checking Initial Appropriateness
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/14/2026
IV
2G
OD
Uti Acute Ap
Checking Initial Appropriateness
05/11/2026
METRONIDAZOLE 500MG (TAB)
05/11/2026
05/17/2026
PO
500mg
Q8
Amoebiasis
Checking Initial Appropriateness